The enigma of increased non-cancer mortality after weight loss in healthy men who are overweight or obese.
(2002) In Journal of Internal Medicine 252(1). p.70-78- Abstract
- Objective. To study effects on non-cancer mortality of observational weight loss in middle-aged men stratified for body mass index (BMI), taking a wide range of possible confounders into account.
Design. Prospective, population based study.
Setting. Male population of Malmö, Sweden.
Participants. In all 5722 men were screened twice with a mean time interval of 6 years in Malmö, southern Sweden. They were classified according to BMI category at baseline (<21, 22-25, overweight: 26-30, and obesity: 30+ kg m-2) and weight change category until second screening (weight stable men defined as having a baseline BMI ± 0.1 kg m-2 year-1 at follow-up re-screening).
Main... (More) - Objective. To study effects on non-cancer mortality of observational weight loss in middle-aged men stratified for body mass index (BMI), taking a wide range of possible confounders into account.
Design. Prospective, population based study.
Setting. Male population of Malmö, Sweden.
Participants. In all 5722 men were screened twice with a mean time interval of 6 years in Malmö, southern Sweden. They were classified according to BMI category at baseline (<21, 22-25, overweight: 26-30, and obesity: 30+ kg m-2) and weight change category until second screening (weight stable men defined as having a baseline BMI ± 0.1 kg m-2 year-1 at follow-up re-screening).
Main outcome measures. Non-cancer mortality calculated from national registers during 16 years of follow-up after the second screening. Data from the first year of follow-up were excluded to avoid bias by mortality caused by subclinical disease at re-screening.
Results. The relative risk (RR; 95% CI) for non-cancer mortality during follow-up was higher in men with decreasing BMI in all subgroups: RR 2.64 (1.46-4.71, baseline BMI <21 kg m-2), 1.39 (0.98-1.95, baseline BMI 22-25 kg m-2), and 1.71 (1.18-2.47, baseline BMI 26+ kg m-2), using BMI-stable men as reference group. Correspondingly, the non-cancer mortality was also higher in men with increasing BMI, but only in the obese group (baseline BMI 26+ kg m-2) with RR 1.86 (1.31-2.65). In a subanalysis, nonsmoking obese (30+ kg m-2) men with decreased BMI had an increased non-cancer mortality compared with BMI-stable obese men (Fischer's test: P=0.001). The mortality risk for nonsmoking overweight men who increased their BMI compared with BMI-stable men was also significant (P=0.006), but not in corresponding obese men (P=0.094).
Conclusions. Weight loss in self-reported healthy but overweight middle-aged men, without serious disease, is associated with an increased non-cancer mortality, which seems even more pronounced in obese, nonsmoking men, as compared with corresponding but weight-stable men. The explanation for these observational findings is still enigmatic but could hypothetically be because of premature ageing effects causing so-called weight loss of involution. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/115218
- author
- Nilsson, Peter LU ; Nilsson, Jan-Åke LU ; Hedblad, Bo LU ; Berglund, Göran LU and Lindgärde, Folke LU
- organization
- publishing date
- 2002
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Population Surveillance, Obesity, Middle Age, Male, Life Style, Non-U.S. Gov't, Human, Cause of Death, Body Mass Index, Sweden, Weight Loss, Prospective Studies, Questionnaires, Registries, Risk Factors, Smoking: adverse effects, Support
- in
- Journal of Internal Medicine
- volume
- 252
- issue
- 1
- pages
- 70 - 78
- publisher
- Wiley-Blackwell
- external identifiers
-
- wos:000176336400010
- pmid:12074741
- scopus:0036309010
- ISSN
- 1365-2796
- DOI
- 10.1046/j.1365-2796.2002.01010.x
- language
- English
- LU publication?
- yes
- additional info
- The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Clinical and Molecular Osteoporosis Research Unit (013242930), Cardio-vascular Epidemiology (013241610), Emergency medicine/Medicine/Surgery (013240200), Internal Medicine Research Unit (013242520)
- id
- b5e62af0-493a-4632-9840-a99bab006116 (old id 115218)
- date added to LUP
- 2016-04-01 16:58:50
- date last changed
- 2024-04-12 11:15:11
@article{b5e62af0-493a-4632-9840-a99bab006116, abstract = {{Objective. To study effects on non-cancer mortality of observational weight loss in middle-aged men stratified for body mass index (BMI), taking a wide range of possible confounders into account.<br/><br> <br/><br> Design. Prospective, population based study.<br/><br> <br/><br> Setting. Male population of Malmö, Sweden.<br/><br> <br/><br> Participants. In all 5722 men were screened twice with a mean time interval of 6 years in Malmö, southern Sweden. They were classified according to BMI category at baseline (<21, 22-25, overweight: 26-30, and obesity: 30+ kg m-2) and weight change category until second screening (weight stable men defined as having a baseline BMI ± 0.1 kg m-2 year-1 at follow-up re-screening).<br/><br> <br/><br> Main outcome measures. Non-cancer mortality calculated from national registers during 16 years of follow-up after the second screening. Data from the first year of follow-up were excluded to avoid bias by mortality caused by subclinical disease at re-screening.<br/><br> <br/><br> Results. The relative risk (RR; 95% CI) for non-cancer mortality during follow-up was higher in men with decreasing BMI in all subgroups: RR 2.64 (1.46-4.71, baseline BMI <21 kg m-2), 1.39 (0.98-1.95, baseline BMI 22-25 kg m-2), and 1.71 (1.18-2.47, baseline BMI 26+ kg m-2), using BMI-stable men as reference group. Correspondingly, the non-cancer mortality was also higher in men with increasing BMI, but only in the obese group (baseline BMI 26+ kg m-2) with RR 1.86 (1.31-2.65). In a subanalysis, nonsmoking obese (30+ kg m-2) men with decreased BMI had an increased non-cancer mortality compared with BMI-stable obese men (Fischer's test: P=0.001). The mortality risk for nonsmoking overweight men who increased their BMI compared with BMI-stable men was also significant (P=0.006), but not in corresponding obese men (P=0.094).<br/><br> <br/><br> Conclusions. Weight loss in self-reported healthy but overweight middle-aged men, without serious disease, is associated with an increased non-cancer mortality, which seems even more pronounced in obese, nonsmoking men, as compared with corresponding but weight-stable men. The explanation for these observational findings is still enigmatic but could hypothetically be because of premature ageing effects causing so-called weight loss of involution.}}, author = {{Nilsson, Peter and Nilsson, Jan-Åke and Hedblad, Bo and Berglund, Göran and Lindgärde, Folke}}, issn = {{1365-2796}}, keywords = {{Population Surveillance; Obesity; Middle Age; Male; Life Style; Non-U.S. Gov't; Human; Cause of Death; Body Mass Index; Sweden; Weight Loss; Prospective Studies; Questionnaires; Registries; Risk Factors; Smoking: adverse effects; Support}}, language = {{eng}}, number = {{1}}, pages = {{70--78}}, publisher = {{Wiley-Blackwell}}, series = {{Journal of Internal Medicine}}, title = {{The enigma of increased non-cancer mortality after weight loss in healthy men who are overweight or obese.}}, url = {{https://lup.lub.lu.se/search/files/4836903/623795.pdf}}, doi = {{10.1046/j.1365-2796.2002.01010.x}}, volume = {{252}}, year = {{2002}}, }